Skip to content

Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia.

Zohaib Nadeem, Stephen Parker, Hugh McGovern, Lena Kl Oestreich

The Australian and New Zealand journal of psychiatry October 1, 2024 DOI: 10.1177/00048674241261779 via PubMed

Summary

AI-generated from the abstract

A survey of 502 Australians, 64.5% of whom self-identified as having a mental illness, found that 43% favored legalizing psychedelics for medical use and 52.4% were open to their use, but only 24% viewed their effects positively and 33% considered them safe. Most participants (61%) had never used psychedelics. People with mental illness were more likely to have used psychedelics (44.1%) than those without (29.7%). Experience, perceived knowledge, and actual knowledge predicted attitudes toward legalization, effects, risks, and openness. While many Australians support medical legalization, safety concerns persist. Those with mental illness, prior recreational use, or greater knowledge held more positive attitudes.

Study at a glance

Characteristics Cross-sectional survey Peer reviewed
Sample size 502
Population Australians, including individuals with and without self-identified mental illness
Topics Depression MDMA Psilocybin Psychedelic-assisted therapy
Keywords Psychedelics
Citations 19
Key finding 43% of Australians favored legalizing psychedelics for medical use, but only 33% considered them safe, and attitudes were significantly predicted by prior psychedelic experience and knowledge.

Abstract

Despite rapid advances in psychedelic sciences and the increasing number of countries legalizing psychedelics for the treatment of mental illnesses, the attitudes, knowledge and readiness of both mental health consumers and the general population remain largely unknown. A cross-sectional survey was conducted among Australians, targeting individuals with mental illness as potential mental health service users. A sub-sample of individuals free of mental illness was also surveyed to assess attitudes in the general population. Participants completed the Attitudes on Psychedelics Questionnaire, the Basic Knowledge of Psychedelics Test and a questionnaire by Corrigan et al. to capture attitudes toward psychedelic therapy by mental health service users. Of the 502 respondents, 64.5% self-identified as having a mental illness. A significant proportion favored legalizing psychedelics for medical use (43%) and were open to their use (52.4%), yet fewer viewed their effects positively (24%) or considered them safe (33%). Most participants reported to be psychedelic naive (61%). Participants with mental illness had significantly more experience with psychedelics than participant free of mental illness (44.1% vs 29.7%). Experience, perceived knowledge and actual knowledge significantly predicted attitudes toward legalization, effects, risks and openness to psychedelics. While a large proportion of Australians are in favor of legalizing psychedelics for medical purposes, concerns about safety remain. People with self-identified mental illness, those with previous recreational psychedelic experience and those with greater knowledge of psychedelics were more likely to have positive attitudes toward psychedelics and psychedelic-assisted therapy.

Explore topics

Comments

No comments yet.

Log in to comment